Risk Factors of Carbapenem-resistant Enterobacteriaceae Acquisition at a Community-based Hospital
Open Access
- 30 June 2020
- journal article
- research article
- Published by The Korean College of Clinical Pharmacy in Korean Journal of Clinical Pharmacy
- Vol. 30 (2) , 120-126
Abstract
Lee Yeonju, Ji Eun Kang, Jung Yeon Ham, Ja Gyun Lee, and Sandy Jeong Rhie. Korean J Clin Pharm 2020;30:120-6. https://doi.org/10.24304/kjcp.2020.30.2.120Keywords
Funding Information
- Ministry of Education (2017R1D1A1B03033389)
- National Research Foundation of Korea (2020R1A2C1009224)
This publication has 18 references indexed in Scilit:
- Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rateJournal of Hospital Infection, 2017
- Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in JapanJournal of Hospital Infection, 2017
- Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae InfectionsAntimicrobial Agents and Chemotherapy, 2017
- The management of multidrug-resistant EnterobacteriaceaeCurrent Opinion in Infectious Diseases, 2016
- Healthcare-associated infections due to carbapenemase-producing Enterobacteriaceae: Bacteriological profile and risk factorsMedecine Et Maladies Infectieuses, 2016
- Carbapenem-resistantEnterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in KoreaInfection & Chemotherapy, 2016
- Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in SingaporeAntimicrobial Resistance & Infection Control, 2015
- Worldwide Experience with the Use of Doripenem against Extended-Spectrum-β-Lactamase-Producing and Ciprofloxacin-Resistant Enterobacteriaceae : Analysis of Six Phase 3 Clinical StudiesAntimicrobial Agents and Chemotherapy, 2010
- Carbapenemases: the Versatile β-LactamasesClinical Microbiology Reviews, 2007
- Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein.Proceedings of the National Academy of Sciences, 1994